News | December 26, 2025
Biofabri and Bharat Biotech ink tech transfer pact to boost global TB vaccine access
BBIL will guarantee production and supply of MTBVAC to more than 70 countries across Africa and Southeast Asia
BBIL will guarantee production and supply of MTBVAC to more than 70 countries across Africa and Southeast Asia
The new site will produce next-generation synthetic medicine active pharmaceutical ingredients
Expands bioprocessing footprint across Asia
With US$ 30.46 billion in exports and robust manufacturing capabilities, the industry is poised to expand into high-value drugs while strengthening ESG and compliance standards
Speakers are: Ch. A. P. Rameswara Rao, National President, BDMAI; Dr. Paidi Yella Reddy, Founder, President & CEO, Sapala Organics; K. V. Rama Gopal, Site Manager & Executive Director, Clariant India; Dr. K. Nagaiah, Chief Scientist, CSIR - Indian Institute of Chemical Technology, Hyderabad; Dr. Satyanarayana Thirunahari, Senior General Manager - Process Safety & Engineering, Laurus Labs; and Yadavendra Shalgaonkar, Assistant General Manager - Tube Sales, Alleima India
Sessions will cover process mapping, cost optimisation, data-driven decision-making, cybersecurity, and sustainable manufacturing practices
It will focus on interface between API and formulation manufacturing, reducing carbon footprint in formulation production, creating intellectual property, training next-generation scientists, and setting new industry benchmarks
Enhance strategies to drive sustainability, global Reach and digital transformation for a trillion-dollar future
Through strong industry cooperation, significant investment, and smart policy backing, API manufacturing may become self-reliant
CDMO business delivered high-teen revenue growth for 9MFY25 driven by continued traction in the on-patent commercial manufacturing and generic API business
Subscribe To Our Newsletter & Stay Updated
